-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
26 May 2022 21:17 GMT
… demonstrated deeper responses vs sunitinib. Regardless of treatment, … non-small cell lung cancer (NSCLC)
Lung cancer is one of … of lung cancer - NSCLC and SCLC (small cell lung cancer). … Organization: GLOBOCAN 2020 – Lung Cancer: Estimated cancer incidence, …
-
Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
25 Jan 2023 04:17 GMT
… chest computed tomography showed lung cancer in the middle (Figure … -rearranged non-small-cell lung cancer patient: a case report … rearrangement non-small-cell lung cancer in a single … Yan M. Crizotinib and sunitinib induce hepatotoxicity and mitochondrial …
-
HUTCHMED Receives a US$15 million Milestone from AstraZeneca for Initiating Start-up Activities for a Global Phase III Study of ORPATHYS® in Lung Cancer
07 Mar 2022 06:00 GMT
… savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed … lung cancer – A systematic review and meta-analysis. Lung Cancer 2018 … non-small-cell lung cancers harbouring MET exon …
-
HUTCHMED and AstraZeneca Initiate SACHI Phase III Trial of ORPATHYS® and TAGRISSO® Combination in Certain Lung Cancer Patients in China After Progression on EGFR Inhibitor Therapy
24 Nov 2021 01:15 GMT
… ;s lung cancer patients are in China.3 Lung cancer is … savolitinib plus IMFINZI® versus sunitinib monotherapy versus IMFINZI® … caregivers/lung-cancer-101/types-of-lung-cancer . Accessed June … other non-small-cell lung cancers harbouring MET exon …
-
Global Lung Cancer Drugs Market Trends, Strategies, And Opportunities In The Lung Cancer Drugs Market 2021-2030
13 Sep 2021 10:54 GMT
… lung cancer drugs market, lung cancer drugs market share, lung cancer drugs market players, lung cancer … drugs market segments and geographies, lung cancer … Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor ( …
-
Chi-Med’s NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China
28 Jul 2020 06:00 GMT
… treatment of non-small cell lung cancer (“NSCLC”) with MET … ’s annual incidence of lung cancer in 2018.1 Approximately … savolitinib monotherapy compared with sunitinib monotherapy in MET-driven … in Non–Small-Cell Lung Cancer Are Associated With Advanced …
-
Exelixis Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results, Provides 2023 Financial Guidance, and Outlines Key Priorities and Milestones for 2023
08 Jan 2023 22:16 GMT
… in combination with nivolumab versus sunitinib in patients with advanced non … tumors including non-small cell lung cancer, head and neck squamous cell …
-
Exelixis Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results, Provides 2023 Financial Guidance, and Outlines Key Priorities and Milestones for 2023
08 Jan 2023 21:20 GMT
… in combination with nivolumab versus sunitinib in patients with advanced non … tumors including non-small cell lung cancer, head and neck squamous cell …
-
Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations
29 May 2020 06:00 GMT
… treatment of non-small cell lung cancer (“NSCLC”) with MET … 1 Annual incidence of lung cancer in China accounted for 37 … savolitinib monotherapy compared with sunitinib monotherapy in MET-positive … in Non–Small-Cell Lung Cancer Are Associated With Advanced …
About
© 1995-2023